Presentation description
Cyclization is a widely used strategy for improving peptide stability, rigidity, and therapeutic potential. While peptides can exhibit high selectivity and efficacy for specific targets, linear peptides are often highly susceptible to proteolytic degradation in the body. Cyclization enhances the resistance of peptides by reducing accessibility to the vulnerable N and C termini. Urazole-based strategies are one approach to peptide cyclization and can offer selectivity in the presence of multiple reactive residues like Tyrosine, Tryptophan, and Histidine, making efficient urazole installation a critical step in the synthetic process. In my work, urazole addition conditions were optimized using the model peptide GPAY to improve the efficiency and practicality of the reaction. Parameters like equivalence, duration, and frequency were evaluated for the reagents Fmoc-NH-NH-COOSu and N,N'-disuccinimiidyl carbonate (DSC). Optimization focused on determining whether reduced reagent consumption and reaction times could maintain effective conversion to the urazole-modified peptide. Additionally, I worked to synthesize the peptide sequences Ac-WFRSHNDap and Ac-YFRSHNDap using solid-phase peptide synthesis. In a previous biological study, similar FRSH-derived peptide sequences have shown potential in the inhibition of the von Willebrand factor-collagen interaction, which may be useful in developing therapeutics for those with thrombotic issues.
Presenter Name: Philip Olesinski
Presentation Type: Poster
Presentation Format: In Person
Presentation #64
College: Science
School / Department: Chemistry
Research Mentor: Andrew Roberts
Additional Mentor: Clare McGrat
Time: 8:30 AM
Physical Location or Zoom link:
Ballroom